Restenosis, defined as the re-narrowing of an arterial lumen after revascularization,
represents an increasingly important issue in clinical practice. Indeed, as the number of stent …

ContextComplications of atherosclerosis cause most morbidity and mortality in patients with
diabetes mellitus. Despite the frequency and severity of disease, proven medical therapy …

Background Optimal treatment for patients with both type 2 diabetes mellitus and stable
ischemic heart disease has not been established. Methods We randomly assigned 2368 …

Background Preliminary reports of studies involving simple coronary lesions indicate that a
sirolimus-eluting stent significantly reduces the risk of restenosis after percutaneous …

Summary Background In the Carotid Revascularization Endarterectomy versus Stenting
Trial (CREST), the composite primary endpoint of stroke, myocardial infarction, or death …

Background—The angiographic presentation of in-stent restenosis (ISR) may convey
prognostic information on subsequent target vessel revascularizations (TLR). Methods and …

Coronary artery stents revolutionized the practice of interventional cardiology after they were
first introduced in the mid-1980s. Since then, there have been significant developments in …

In patients with stable CAD, PCI can be considered a valuable initial mode of
revascularization in all patients with objective large ischaemia in the presence of almost …

Restenosis is a complex disease for which the pathophysiological mechanisms have not yet
been fully elucidated, but are thought to include inflammation, proliferation, and matrix …

To assess platelet function profiles in diabetic and nondiabetic patients on aspirin and
clopidogrel therapy, two patient populations were included to investigate the 1) acute effects …